Cargando…

P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS

Detalles Bibliográficos
Autores principales: Tan, Tran-Der, Chiou, Lun-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429569/
http://dx.doi.org/10.1097/01.HS9.0000969176.88981.2a
_version_ 1785090747514486784
author Tan, Tran-Der
Chiou, Lun-Wei
author_facet Tan, Tran-Der
Chiou, Lun-Wei
author_sort Tan, Tran-Der
collection PubMed
description
format Online
Article
Text
id pubmed-10429569
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104295692023-08-17 P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS Tan, Tran-Der Chiou, Lun-Wei Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429569/ http://dx.doi.org/10.1097/01.HS9.0000969176.88981.2a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Tan, Tran-Der
Chiou, Lun-Wei
P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS
title P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS
title_full P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS
title_fullStr P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS
title_full_unstemmed P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS
title_short P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS
title_sort p568: comparison of venetoclax-based induction therapy or 3 + 7 followed by allogeneic hematopoietic stem cell transplantation for newly diagnosed aml patients
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429569/
http://dx.doi.org/10.1097/01.HS9.0000969176.88981.2a
work_keys_str_mv AT tantrander p568comparisonofvenetoclaxbasedinductiontherapyor37followedbyallogeneichematopoieticstemcelltransplantationfornewlydiagnosedamlpatients
AT chioulunwei p568comparisonofvenetoclaxbasedinductiontherapyor37followedbyallogeneichematopoieticstemcelltransplantationfornewlydiagnosedamlpatients